220 related articles for article (PubMed ID: 18217914)
21. Recurent and de novo membranous glomerulopathy after kidney transplantation.
Aline-Fardin A; Rifle G; Martin L; Justrabo E; Bour JB; D'Athis P; Tanter Y; Mousson C
Transplant Proc; 2009 Mar; 41(2):669-71. PubMed ID: 19328952
[TBL] [Abstract][Full Text] [Related]
22. De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney.
Honda K; Horita S; Toki D; Taneda S; Nitta K; Hattori M; Tanabe K; Teraoka S; Oda H; Yamaguchi Y
Clin Transplant; 2011; 25(2):191-200. PubMed ID: 20236137
[TBL] [Abstract][Full Text] [Related]
23. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report.
Sirimongkolrat T; Premasathian N; Vongwiwatana A; Limsrichamrern S; Cheunsuchon B; Vasuvattakul S
Transplant Proc; 2008 Sep; 40(7):2440-1. PubMed ID: 18790261
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
25. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
26. [A case of membranous glomerulonephritis in renal allograft].
Kanno T; Ito M; Kawase N; Taki Y; Yoshida H; Okuno H; Ogawa O
Hinyokika Kiyo; 2002 Jun; 48(6):379-82. PubMed ID: 12166242
[TBL] [Abstract][Full Text] [Related]
27. Detailed examination of HLA antibody development on renal allograft failure and function.
Zhu L; Lee PC; Everly MJ; Terasaki PI
Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
[TBL] [Abstract][Full Text] [Related]
28. Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series.
Batal I; Vasilescu ER; Dadhania DM; Adel AA; Husain SA; Avasare R; Serban G; Santoriello D; Khairallah P; Patel A; Moritz MJ; Latulippe E; Riopel J; Khallout K; Swanson SJ; Bomback AS; Mohan S; Ratner L; Radhakrishnan J; Cohen DJ; Appel GB; Stokes MB; Markowitz GS; Seshan SV; De Serres SA; Andeen N; Loupy A; Kiryluk K; D'Agati VD
Am J Kidney Dis; 2020 Sep; 76(3):374-383. PubMed ID: 32359820
[TBL] [Abstract][Full Text] [Related]
29. A primer on recurrent and de novo glomerulonephritis in renal allografts.
Ivanyi B
Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
[TBL] [Abstract][Full Text] [Related]
30. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
31. Focal segmental glomerulosclerosis after membranous glomerulonephritis in remission: temporal diversity of glomerulopathy after bone marrow transplantation.
Chan GS; Chim S; Fan YS; Chan KW
Hum Pathol; 2006 Dec; 37(12):1607-10. PubMed ID: 17020780
[TBL] [Abstract][Full Text] [Related]
32. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
Obayashi M; Uzu T; Harada T; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
[TBL] [Abstract][Full Text] [Related]
33. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.
Lefaucheur C; Suberbielle-Boissel C; Hill GS; Nochy D; Andrade J; Antoine C; Gautreau C; Charron D; Glotz D
Contrib Nephrol; 2009; 162():1-12. PubMed ID: 19001809
[TBL] [Abstract][Full Text] [Related]
35. Membranous nephropathy: monoclonal IgG and nephrotic-range proteinuria in a renal transplant recipient.
Short CD; Coupes BM; Brenchley PE; Martin S; Williams S; Johnson RW; Mallick NP; Williams G
Nephrol Dial Transplant; 1989; 4(12):1080-2. PubMed ID: 2517330
[No Abstract] [Full Text] [Related]
36. Recurrence of de novo membranous glomerulonephritis on renal grafts.
Heidet L; Gagnadoux ME; Beziau A; Niaudet P; Broyer M; Habib R
Clin Nephrol; 1994 May; 41(5):314-8. PubMed ID: 8050213
[TBL] [Abstract][Full Text] [Related]
37. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
Lachmann N; Terasaki PI; Schönemann C
Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
[TBL] [Abstract][Full Text] [Related]
38. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
39. Experience with antibody-mediated rejection in kidney allograft recipients.
Wade E; Goral S; Kearns J; Pierce E; Trofe J; Bloom R; Kamoun M
Clin Transpl; 2006; ():439-46. PubMed ID: 18365401
[TBL] [Abstract][Full Text] [Related]
40. Transplant glomerulopathy: morphology, associations and mechanism.
Fotheringham J; Angel CA; McKane W
Nephron Clin Pract; 2009; 113(1):c1-7; discussion c7. PubMed ID: 19590229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
